Presentation Information

[S1-01]Regulatory perspectives for preparing for the next pandemic

SHIOKAWA Tomonori (1. Pharmaceuticals and Medical Devices Agency (PMDA) (Japan))

Keywords:

Pharmaceutical regulation,Vaccines

Login required to view


Comment

To browse or post comments, you must log in.Log in